Nikkiso Co., Ltd. 6376
TSE · Japonya · Üretici İmalatı
¥3.600,00+50,00 (+%1,41)
Piyasa kapalı· · JPY · Veriler gecikmeli olabilir
Fiyatlar gecikmeli olabilir ve yalnızca bilgilendirme amaçlıdır - yatırım tavsiyesi değildir.
Piyasa kapalı· · JPY · Veriler gecikmeli olabilir
Fiyatlar gecikmeli olabilir ve yalnızca bilgilendirme amaçlıdır - yatırım tavsiyesi değildir.
[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Therapeutic Apheresis Market size & share revenue was valued at approximately USD 3.84 Billion in 2025 and is expected to reach USD 4.18 Billion in 2026 and is expected to reach around USD 8.94 Billion by 2035, at a CAGR of 7.9% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Terumo BCT Inc., Fresenius K
As global markets navigate through inflationary pressures and rising energy costs, investor sentiment in Asia remains cautiously optimistic, with regional equities showing resilience amid geopolitical uncertainties. In this dynamic environment, identifying promising opportunities involves seeking companies that demonstrate strong fundamentals and potential for growth despite broader economic challenges.
Nikkiso (TSE:6376) has drawn investor attention after a May 15, 2026 board meeting focused on an asset disposal, including its purpose, the trust structure, and the method used to calculate the disposal price. See our latest analysis for Nikkiso. Nikkiso’s recent asset disposal discussions come after a period of strong share price momentum, with a 90 day share price return of 27.40% and a year to date share price return of 79.80%. The 1 year total shareholder return stands at 143.53%. If this...
Üçüncü taraf yayıncıların bu şirket hakkındaki son başlıkları; Makkler'in kendi editoryal içeriğinden ayrı tutulur ve dış kaynağa yönlendirir. Başlıkların doğruluğu ilgili yayıncının sorumluluğundadır.